Effect of Sodium Valproate on Adenomyosis

Phase 3

Recruiting

• Conditions: Adenomyosis.; Endometriosis of uterus; N80.0

• Registration Number: IRCT20110731007165N6
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 42

Inclusion Criteria

Having clinical symptoms of adenomyosis (chronic pelvic pain, Heavy Menorrhagia, abnormal uterine bleeding, acute Dysmenorrhea, Dyspareunia, enlargement of the uterus, tenderness of the uterus)
Pelvic examination suggestive of Adenomyosis
Transvaginal ultrasound diagnostic findings of Adenomyosis

Exclusion Criteria

Pregnancy, suspicion of pregnancy or planning to become pregnant
Breastfeeding
Hepatic, renal, heart and internal diseases
Lack of patient collaboration or desire to performing the hysterectomy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dysmenorrhea. Timepoint: At the beginning of the study (before the intervention) and 1, 2, 3, 4, 5 and 6 months after starting the intervention. Method of measurement: Visual Analogue Scale.;Uterine Size. Timepoint: At the beginning of the study (before the intervention) and 6 months after starting the intervention. Method of measurement: Ultrasound.;The statues of the palpable nodule in the vaginal examination. Timepoint: At the beginning of the study (before the intervention) and 1, 2, 3, 4, 5 and 6 months after starting the intervention. Method of measurement: Vaginal Examination.